Back
Day Range
$30.50
$31.97
52-Week Range
$14.40
$31.99
Volume
670,906
50D / 200D Avg
$26.77
/
$24.92
Prev Close
$31.80
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.0 | 0.4 |
| P/B | 3.9 | 2.9 |
| ROE % | -40.6 | 3.9 |
| Net Margin % | -17253.3 | 3.8 |
| Rev Growth 5Y % | -24.6 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$24.00
-23.1%
Forward EPS
-$4.83
Est. Revenue
2.63M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.15
-$0.43 – $12.49
|
890.91M | 3 |
| FY2029 |
-$0.16
-$0.47 – $0.02
|
471.29M | 3 |
| FY2028 |
-$3.63
-$5.17 – -$1.55
|
126.54M | 9 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -24.64% annually over 5 years
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -213.66M
Revenue growth is decelerating — 1Y growth trails 5Y average by 53.99%
Capital intensive — 180.93% of revenue goes to capex
Growth
Revenue Growth (5Y)
-24.64%
Revenue (1Y)-78.63%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-40.62%
ROIC-40.71%
Net Margin-17253.33%
Op. Margin-19160.00%
Safety
Debt / Equity
0.00
Current Ratio10.49
Interest Coverage0.00
Valuation
P/E Ratio
-8.02
Forward P/EN/A
P/B Ratio3.94
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -78.63% | Revenue Growth (3Y) | -53.32% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -24.64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.50M | Net Income (TTM) | -258.80M |
| ROE | -40.62% | ROA | -44.39% |
| Gross Margin | 100.00% | Operating Margin | -19160.00% |
| Net Margin | -17253.33% | Free Cash Flow (TTM) | -213.66M |
| ROIC | -40.71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 10.49 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.02 | Forward P/E | N/A |
| P/B Ratio | 3.94 | P/S Ratio | 1384.14 |
| PEG Ratio | -0.12 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -10.29% | ||
| Market Cap | 2.08B | Enterprise Value | 2.05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.50M | 7.02M | 6.88M | 2.36M | 4.65M |
| Net Income | -258.80M | -157.86M | -141.43M | -112.33M | -70.51M |
| EPS (Diluted) | -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
| Gross Profit | 1.50M | -156.53M | -111.13M | -79.90M | -48.66M |
| Operating Income | -287.40M | -195.08M | -154.54M | -115.23M | -71.24M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 582.98M | 792.34M | 465.63M | 352.74M | 444.65M |
| Total Liabilities | 55.82M | 45.34M | 36.46M | 26.53M | 25.18M |
| Shareholders' Equity | 527.17M | 747.01M | 429.17M | 326.20M | 419.48M |
| Total Debt | 2.34M | 3.81M | 2.54M | 4.03M | 3.04M |
| Cash & Equivalents | 28.87M | 28.36M | 34.81M | 29.43M | 39.14M |
| Current Assets | 534.66M | 747.16M | 431.69M | 317.69M | 410.84M |
| Current Liabilities | 50.99M | 39.50M | 31.13M | 18.61M | 16.53M |